Mansour R, Shaker A, Abulsoud A, Mageed S, Ashraf A, Elsakka E
Mol Neurobiol. 2025; .
PMID: 40009259
DOI: 10.1007/s12035-025-04750-7.
Toader C, Tataru C, Munteanu O, Serban M, Covache-Busuioc R, Ciurea A
Int J Mol Sci. 2024; 25(23.
PMID: 39684324
PMC: 11641752.
DOI: 10.3390/ijms252312613.
Mohseni M, Behzad G, Farhadi A, Behroozi J, Mohseni H, Valipour B
Front Neurosci. 2024; 18:1397106.
PMID: 39582602
PMC: 11582054.
DOI: 10.3389/fnins.2024.1397106.
Luo C, Yang J
Aging Cell. 2024; 23(8):e14285.
PMID: 39044402
PMC: 11320343.
DOI: 10.1111/acel.14285.
Beatriz M, Vilaca R, Anjo S, Manadas B, Januario C, Rego A
J Extracell Biol. 2024; 1(10):e65.
PMID: 38939215
PMC: 11080813.
DOI: 10.1002/jex2.65.
Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington's disease.
Shafie A, Ashour A, Anwar S, Anjum F, Hassan M
Arch Pharm Res. 2024; 47(6):571-595.
PMID: 38764004
DOI: 10.1007/s12272-024-01499-w.
Exploiting Natural Niches with Neuroprotective Properties: A Comprehensive Review.
Moukham H, Lambiase A, Barone G, Tripodi F, Coccetti P
Nutrients. 2024; 16(9).
PMID: 38732545
PMC: 11085272.
DOI: 10.3390/nu16091298.
Huntington's Disease: Complex Pathogenesis and Therapeutic Strategies.
Tong H, Yang T, Xu S, Li X, Liu L, Zhou G
Int J Mol Sci. 2024; 25(7).
PMID: 38612657
PMC: 11011923.
DOI: 10.3390/ijms25073845.
Rapamycin reduces neuronal mutant huntingtin aggregation and ameliorates locomotor performance in .
Roth J, de Moraes R, Xu B, Crawley S, Khan M, Melkani G
Front Aging Neurosci. 2023; 15:1223911.
PMID: 37823007
PMC: 10562706.
DOI: 10.3389/fnagi.2023.1223911.
Targeting the autophagy-lysosomal pathway in Huntington disease: a pharmacological perspective.
Yang J, Zhang C
Front Aging Neurosci. 2023; 15:1175598.
PMID: 37304076
PMC: 10248240.
DOI: 10.3389/fnagi.2023.1175598.
Fountain of youth-Targeting autophagy in aging.
Danics L, Abbas A, Kis B, Pircs K
Front Aging Neurosci. 2023; 15:1125739.
PMID: 37065462
PMC: 10090449.
DOI: 10.3389/fnagi.2023.1125739.
Co-Expression Network Analysis Identifies Molecular Determinants of Loneliness Associated with Neuropsychiatric and Neurodegenerative Diseases.
Santiago J, Quinn J, Potashkin J
Int J Mol Sci. 2023; 24(6).
PMID: 36982982
PMC: 10058494.
DOI: 10.3390/ijms24065909.
The Impact of Dysregulated microRNA Biogenesis Machinery and microRNA Sorting on Neurodegenerative Diseases.
Weng Y, Chang Y, Chern Y
Int J Mol Sci. 2023; 24(4).
PMID: 36834853
PMC: 9959302.
DOI: 10.3390/ijms24043443.
Intracellular and intercellular transport of RNA organelles in CXG repeat disorders: The strength of weak ties.
Nabariya D, Heinz A, Derksen S, Krauss S
Front Mol Biosci. 2023; 9:1000932.
PMID: 36589236
PMC: 9800848.
DOI: 10.3389/fmolb.2022.1000932.
The length of uninterrupted CAG repeats in stem regions of repeat disease associated hairpins determines the amount of short CAG oligonucleotides that are toxic to cells through RNA interference.
Murmann A, Patel M, Jeong S, Bartom E, Morton A, Peter M
Cell Death Dis. 2022; 13(12):1078.
PMID: 36585400
PMC: 9803637.
DOI: 10.1038/s41419-022-05494-1.
Fragment-based virtual screening identifies a first-in-class preclinical drug candidate for Huntington's disease.
Galyan S, Ewald C, Jalencas X, Masrani S, Meral S, Mestres J
Sci Rep. 2022; 12(1):19642.
PMID: 36385140
PMC: 9668931.
DOI: 10.1038/s41598-022-21900-2.
Gene Alterations Induced by Glutamine (Q) Encoding CAG Repeats Associated with Neurodegeneration.
Saha G, Ghosh S, Dubey V, Saudagar P
Methods Mol Biol. 2022; 2575:3-23.
PMID: 36301468
DOI: 10.1007/978-1-0716-2716-7_1.
Epigenetic Changes in Prion and Prion-like Neurodegenerative Diseases: Recent Advances, Potential as Biomarkers, and Future Perspectives.
Hernaiz A, Toivonen J, Bolea R, Martin-Burriel I
Int J Mol Sci. 2022; 23(20).
PMID: 36293477
PMC: 9604074.
DOI: 10.3390/ijms232012609.
The emerging role of long non-coding RNAs, microRNAs, and an accelerated epigenetic age in Huntington's disease.
Ghafouri-Fard S, Khoshbakht T, Hussen B, Taheri M, Ebrahimzadeh K, Noroozi R
Front Aging Neurosci. 2022; 14:987174.
PMID: 36185471
PMC: 9520620.
DOI: 10.3389/fnagi.2022.987174.
Age-related pathological impairments in directly reprogrammed dopaminergic neurons derived from patients with idiopathic Parkinson's disease.
Drouin-Ouellet J, Legault E, Nilsson F, Pircs K, Bouquety J, Petit F
Stem Cell Reports. 2022; 17(10):2203-2219.
PMID: 36150382
PMC: 9561608.
DOI: 10.1016/j.stemcr.2022.08.010.